Duke Ortho, CTSI Launch Five-Year Pain Study
The Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk) project will build on a successful pilot study completed by Duke Ortho and CTSI in August. Like the pilot, recruitment for the BACk study will take place in Durham and Kannapolis, where CTSI operates the Duke Kannapolis research site on the North Carolina Research Campus.
Duke Kannapolis COVID-19 Study Illuminates Factors Surrounding Vaccination
Analysis of a COVID-19 research study based at CTSI’s Duke Kannapolis site found that education level, household income, and baseline intention were associated with longer times to vaccination, and the most common reasons for not being vaccinated were safety concerns, side effects, and vaccine effectiveness.
New Center for Precision Health Aims to Transform Population Health, Patient Care
The Duke Clinical and Translational Science Institute (CTSI) is pleased to announce the launch of the Center for Precision Health (CPH), a collaboration that will harness the power of genomic, biomarker, and health data to transform patient care and population health.
Duke Diabetes Researchers Use MURDOCK Study to Find Markers for Fracture Risk
Samples and data from the MURDOCK Study helped Duke University researchers identify new indicators of fracture risk among older adults with type 2 diabetes.
MURDOCK Samples, Data Advance Alzheimer’s Research at Duke
Using samples and data from the MURDOCK Study, Duke University researchers have found more evidence linking the disruption of a key metabolic pathway with the development of Alzheimer’s disease.
MURDOCK Samples Accelerate Heart Failure Discovery
The ease and speed of obtaining samples and data from a groundbreaking community-based biorepository at Duke Kannapolis helped to accelerate a recent heart failure discovery by Duke researchers.
Svati Shah Awarded Distinguished Professorship
Svati H. Shah, MD, MHS, director of CTSI's research site at Duke Kannapolis, has been awarded a Distinguished Professorship.
Duke Launches Site for COVID Vaccine Study Among Health Care Workers
The Duke Clinical and Translational Science Institute (CTSI) is collaborating with Duke Emergency Medicine on a public health surveillance project dubbed Preventing Emerging Infections Through Vaccine Effectiveness Testing, or PREVENT II. Anyone who works at a Duke Health location and has recently been tested for COVID-19, whether positive or negative for infection, may be eligible to participate.
Duke Kannapolis Data Tool Accelerates Research for Investigators
With just a few clicks, a new data exploration tool developed by the Duke Clinical and Translational Science Institute (CTSI) research site in Kannapolis enables Duke investigators to quickly identify populations of interest, accelerating their research.
Duke Kannapolis Director Outlines Future at North Carolina Research Campus
Svati H. Shah, MD, MHS, spoke to partners at the North Carolina Research Campus (NCRC) about the pivotal role of Duke Kannapolis at the 350-acre translational science hub focused on human health and nutrition.